388870 — Pharos IBio Co Balance Sheet
0.000.00%
- KR₩98bn
- KR₩90bn
Annual balance sheet for Pharos IBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 23,812 | 15,079 | 25,487 | 15,668 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 67.4 | 225 | 280 | 265 |
| Prepaid Expenses | ||||
| Total Current Assets | 24,422 | 15,715 | 26,170 | 16,254 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 2,700 | 2,541 | 3,218 | 2,817 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 27,486 | 18,721 | 29,690 | 19,628 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 78,088 | 951 | 1,213 | 973 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 78,670 | 1,056 | 1,341 | 1,015 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -51,184 | 17,665 | 28,349 | 18,614 |
| Total Liabilities & Shareholders' Equity | 27,486 | 18,721 | 29,690 | 19,628 |
| Total Common Shares Outstanding |